a.petrov

TL2 · Dhaka

Contributes reviews on supplier material. Based in Dhaka.

Joined 22 December 2024 · last posted 4d

78 posts, newest first. Showing up to 150.

Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #64 · Practice › Interactions · 24 Jul 2026 · 28 likes Adding the measurement that post #61 says would settle it. Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #95 · Analytics › Home & field testing · 17 Jul 2026 · 3 likes That is a cleaner way of putting what I was circling around.
How shortages have affected compounding permissions Replied, post #45 · Access › Shortages · 17 Jul 2026 · 9 likes Helpful, and easy to find again, which is half of what a good reply is.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #76 · Analytics › Home & field testing · 12 Jul 2026 · 4 likes A note on how consumer-accessible tests gets discussed rather than on consumer-accessible tests itself: the confident posts get the replies and the careful ones get…
Tirzepatide storage and stability: what is published versus what is assumed Started this topic · Compounds › Tirzepatide · 9 Jul 2026 · 1 like On the subject in the title: Tirzepatide storage and stability: what is published versus what is assumed Working notes rather than a conclusion. Asking about…
Documenting a supplier's response to a discrepancy Replied, post #21 · Sourcing › Vendor reports · 23 Jun 2026 · 1 like Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. Not the whole picture, but the part of it…
Prescription portability between countries Replied, post #69 · Access › International · 19 Jun 2026 · 21 likes Where I part company with post #67, and it is a narrow parting. Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking…
I have no scientific background — can I still follow the analytics categories? Replied, post #21 · Start Here › Welcome · 17 Jun 2026 · 4 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #31 · Compounds › Secretagogues & GH axis · 11 Jun 2026 · 0 likes On analysis: these are short peptides and generally straightforward chromatographically, which means a poor purity result is more likely to reflect the synthesis than…
Does dual agonism explain the effect size, or is it dose? Replied, post #20 · Compounds › Tirzepatide · 6 Jun 2026 · 27 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #77 · Sourcing › Red flags · 6 Jun 2026 · 16 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
What I would want from a home test that does not exist yet Started this topic · Analytics › Home & field testing · 29 May 2026 · 7 likes The question in the title: What I would want from a home test that does not exist yet I will give what I have already checked below so nobody repeats it. Two reports on…
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #37 · Start Here › Welcome · 27 May 2026 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #36 · Clinical › Bloodwork · 25 May 2026 · 15 likes Marking my uncertainty on Liver enzymes drifting explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
Reading a trial's population section before its results Replied, post #48 · Evidence › Trials · 24 May 2026 · 9 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Blind submission and why it changes minds — the long version Replied, post #70 · Sourcing › Independent verification · 11 May 2026 · 26 likes Where the Blind submission reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Why the timeline is on the right and not the left — what changed since Replied, post #32 · Meta › Site feedback · 7 May 2026 · 6 likes My experience of timeline contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #33 · Practice › Reconstitution · 3 May 2026 · 0 likes Building on post #32 rather than restating it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #13 · Practice › Storage & stability · 2 May 2026 · 10 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Second-hand, so weight it accordingly.
Request: show the solution author in the topic list — what changed since Replied, post #8 · Meta › Feature requests · 30 Apr 2026 · 31 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications. It reads as pedantry until…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #10 · Compounds › Tirzepatide · 30 Apr 2026 · 0 likes My position on Tirzepatide and nausea is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Journal club: is percentage weight change the right endpoint? Replied, post #29 · Evidence › Journal club · 1 Apr 2026 · 14 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
Grapefruit: why this class is not the class that cares Replied, post #57 · Practice › Interactions · 19 Mar 2026 · 0 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #92 · Wellbeing › Mental health · 16 Feb 2026 · 3 likes I had written a reply contradicting post #88 and deleted it. Here is what survived. When to involve a professional: if mood changes are persistent, deepen over weeks,…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #42 · Start Here › Welcome · 14 Feb 2026 · 14 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Trifluoroacetate content and its consequences Replied, post #94 · Analytics › Impurities & related substances · 6 Feb 2026 · 5 likes Where I would push back on the trifluoroacetate content consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Distinguishing expected GI effects from something that needs urgent attention Replied, post #8 · Practice › Side effects · 31 Dec 2025 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #40 · Data & Tools › Calculators · 15 Dec 2025 · 5 likes Post #38 describes the usual case. This is about the unusual one. The residual-volume question belongs in the tool rather than in a footnote, because it is the…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #24 · Compounds › Retatrutide · 13 Dec 2025 · 4 likes Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious plateau within it. Extrapolating beyond the highest studied dose from that…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #3 · Practice › Administration · 5 Dec 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Injecting into an area that has become firm: lipohypertrophy — thickened…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #104 · Sourcing › Vendor reports · 5 Dec 2025 · 2 likes The service matters to the interpretation. A documentation review and a chromatographic assay answer different questions and both are worth filing. That is where I…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #19 · Compounds › Tirzepatide · 2 Dec 2025 · 5 likes Post #15 put the caveat in the right place and I want to underline it. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed…
Tracking that stops updating and then resumes Replied, post #47 · Sourcing › Logistics · 18 Nov 2025 · 11 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. It is a small point and it changes the answer, which is…
[2026 update] Splitting an overlong document into two Replied, post #48 · Documentation › Wiki requests · 7 Nov 2025 · 1 like Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change. Reading it again, the caveat…
New subcategory: rationale and scope Replied, post #110 · Meta › Announcements · 24 Oct 2025 · 26 likes Building on post #107 rather than restating it. My position on new subcategory is current rather than settled. I have revised it once already and I expect to again, so…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #82 · Devices › Cold chain · 27 Sep 2025 · 7 likes Post #79 answers the question as asked. The question underneath it is different. A parcel sitting in a vehicle or a depot in a hot month is the excursion that matters…
Which panel is worth repeating and which is worth ignoring Replied, post #115 · Clinical › Bloodwork · 19 Sep 2025 · 5 likes General information rather than advice about anyone's care. A single value outside a reference interval, on a single draw, in an otherwise unremarkable panel, is…
Gauge and length selection for subcutaneous injection Replied, post #28 · Devices › Syringes & needles · 9 Sep 2025 · 10 likes Post #25 is the version of this I will quote in future. One addition. An update on my earlier gauge and length selection post: the pattern held for another six weeks…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #66 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes Picking up post #63: that is the part I would want checked first. Having read the whole Aggregated purity results across four thread before replying: the question in…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #116 · Compounds › Tirzepatide · 31 Aug 2025 · 3 likes Post #113 answers the question as asked. The question underneath it is different. Comparisons between the tirzepatide and semaglutide programmes across trials rather…
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #16 · Compounds › Tirzepatide · 26 Aug 2025 · 1 like Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #31 · Evidence › Journal club · 14 Aug 2025 · 12 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #17 · Analytics › COA interpretation · 8 Aug 2025 · 19 likes Marking my place. If it changes for me I will come back and say so.
Follow-up: The decimal-point error, and the habit that catches it Replied, post #38 · Practice › Reconstitution · 8 Aug 2025 · 4 likes Marking my uncertainty on decimal-point error explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
How to research a compound with no human data without deceiving yourself Replied, post #48 · Compounds › Other compounds · 1 Aug 2025 · 20 likes Coming back to post #45, because the follow-up matters more than the original answer. How to research a compound with no human data: mechanistic plausibility is one…
Asking about a compound your prescriber has not heard of Replied, post #103 · Clinical › Prescriber conversations · 23 Jul 2025 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Comparing my trajectory with the trial curves, carefully Replied, post #27 · Outcomes › Progress reports · 22 Jul 2025 · 10 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #72 · Compounds › Repair & healing peptides · 17 Jul 2025 · 8 likes Post #70 describes the usual case. This is about the unusual one. Practical note on TB-500 and thymosin beta-4: write down what you expect before you look. The number…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2025 · 0 likes I read post #36 twice before replying, because I had assumed the opposite. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does…
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #9 · Practice › Dosing & titration · 7 Jul 2025 · 23 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
Repeatability versus intermediate precision Replied, post #102 · Analytics › Method validation · 30 Jun 2025 · 2 likes Post #100 describes the usual case. This is about the unusual one. Repeatability versus intermediate precision came up in a thread eighteen months ago and was answered…
Pre-registering a personal experiment, seriously Replied, post #86 · Research Methods › N-of-1 designs · 2 Jun 2025 · 10 likes Measure the same thing the same way at the same time of day. Most of the noise in personal data is measurement protocol rather than biology. This is the sort of thing…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #5 · Documentation › Doc review · 24 May 2025 · 17 likes Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the document rather than the reverse. It is worth checking rather…
Pregnancy as an absolute contraindication Replied, post #44 · Safety › Contraindications · 18 May 2025 · 0 likes This follows post #41 rather than contradicting it. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close…
Pen wastage and its effect on real cost — the long version Replied, post #2 · Access › Pricing · 17 May 2025 · 0 likes Where somebody posts a comparison, the useful version states the date, the region and what was included. A qualification I should have led with rather than closed on.
A supplier that answers analytical questions with restated claims Replied, post #72 · Sourcing › Red flags · 8 May 2025 · 16 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
Antibiotics and a course of something with delayed emptying Replied, post #27 · Practice › Interactions · 24 Apr 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
Requesting a page: what makes a good request Replied, post #41 · Documentation › Wiki requests · 1 Apr 2025 · 10 likes Coming back to post #39, because the follow-up matters more than the original answer. Format suggestions: if you think a maintained page could be clearer in its…
Checking someone else's arithmetic: a worked example thread Replied, post #32 · Practice › Reconstitution · 24 Mar 2025 · 15 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Not the whole…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #118 · Access › International · 23 Mar 2025 · 9 likes On post #115 — agreed on the reasoning, with one qualification. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #60 · Practice › Reconstitution · 22 Mar 2025 · 6 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
Maintainer handover: how it works Replied, post #22 · Meta › Wiki maintenance · 14 Mar 2025 · 32 likes Everything in post #18 holds. The case it does not cover is the one I have. Cross-referencing: if two pages should reference each other but do not, suggesting the…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #101 · Sourcing › Regulatory · 4 Mar 2025 · 2 likes I would rather this thread reach "we do not know" about pharmaceutical compounding rules than reach a confident answer that nobody can support when asked.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #27 · Compounds › Semaglutide · 3 Mar 2025 · 0 likes This follows post #25 rather than contradicting it. Small correction to my own earlier position on SELECT. I had the units the wrong way round, which changes the…
Distinguishing a deletion sequence by mass alone Replied, post #130 · Analytics › Mass spectrometry · 24 Feb 2025 · 0 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
Coming back to: How to tell whether your question is already answered on a maintained page Started this topic · Start Here › Welcome · 7 Feb 2025 · 20 likes How to tell whether your question is already answered on a maintained page I have a specific reason for asking rather than idle curiosity, and the context is below.…
Protein density versus volume when you cannot eat much Replied, post #51 · Nutrition & Training › Protein & intake · 1 Feb 2025 · 22 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here.
Isotonicity and what happens when you get it wrong Replied, post #32 · Pharmacology › Formulation chemistry · 18 Jan 2025 · 11 likes This follows post #29 rather than contradicting it. Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #47 · Compounds › Cagrilintide & amylin analogues · 8 Jan 2025 · 1 like Where I part company with post #45, and it is a narrow parting. On analysis: an amylin analogue and its aggregates are not equally detectable by a standard…
The topic list is dense — is that deliberate? Replied, post #79 · Meta › Site feedback · 8 Jan 2025 · 2 likes Post #75 put the caveat in the right place and I want to underline it. The counter-argument is that a review date on a topic implies a maintenance promise nobody has…
Coming back to: When to suspect the method rather than the sample Replied, post #114 · Analytics › Method validation · 22 Dec 2024 · 0 likes This follows post #113 rather than contradicting it. Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #7 · Pharmacology › Receptor biology · 18 Dec 2024 · 25 likes Worth separating two things that post #3 runs together. Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #99 · Compounds › Repair & healing peptides · 20 Nov 2024 · 15 likes Post #95 put the caveat in the right place and I want to underline it. Distinguishing three things in the reading a preclinical wound-healing model discussion that keep…
Gallbladder disease risk with rapid weight loss Replied, post #24 · Clinical › Comorbidities · 28 Oct 2024 · 7 likes Worth separating two things that post #20 runs together. Something worth flagging about gallbladder disease risk: the strongest-sounding claims in this thread are the…
Journal club: SURMOUNT-1, read without the press release Replied, post #6 · Evidence › Journal club · 24 Oct 2024 · 0 likes My position on SURMOUNT-1 is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Blind submission and why it changes minds Replied, post #38 · Sourcing › Independent verification · 17 Aug 2024 · 7 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. I would put…
Second pass at: Reimbursement variation across member states Started this topic · Regional › European Union · 12 Aug 2024 · 0 likes On the subject in the title: Second pass at: Reimbursement variation across member states Working notes rather than a conclusion. The question about Reimbursement…
Guidelines revision: what changed and why Replied, post #99 · Meta › Announcements · 28 Jul 2024 · 1 like Practical note on guidelines revision: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would…